AG
CVS icon

Ascent Group’s CVS Health CVS Stock Holding History

Ascent Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$661K Buy
9,207
+123
+1% +$9.47K 0.02% 443
2025
Q4 		$721K Buy
9,084
+2,184
+32% +$172K 0.02% 429
2025
Q3 		$520K Buy
6,900
+160
+2% +$11K 0.02% 496
2025
Q2 		$465K Sell
6,740
-599
-8% -$39.3K 0.02% 485
2025
Q1 		$497K Buy
+7,339
New +$439K 0.02% 460
2024
Q3 		– Sell
-20,188
Closed -$1.19M – 528
2024
Q2 		$1.19M Buy
20,188
+2,578
+15% +$161K 0.1% 247
2024
Q1 		$1.4M Buy
17,610
+14,693
+504% +$1.12M 0.12% 233
2023
Q4 		$225K Buy
+2,917
New +$208K 0.02% 464
2023
Q3 		– Sell
-5,842
Closed -$432K – 461
2023
Q2 		$432K Sell
5,842
-2,700
-32% -$192K 0.05% 327
2023
Q1 		$635K Sell
8,542
-2,074
-20% -$174K 0.07% 281
2022
Q4 		$989K Sell
10,616
-1,686
-14% -$163K 0.12% 221
2022
Q3 		$1.17M Sell
12,302
-2,613
-18% -$259K 0.14% 196
2022
Q2 		$1.43M Sell
14,915
-3,217
-18% -$314K 0.17% 179
2022
Q1 		$1.83M Sell
18,132
-1,127
-6% -$118K 0.21% 167
2021
Q4 		$1.96M Buy
+19,259
New +$1.78M 0.25% 149

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ascent Group's CVS Position: Q1 2026 in Review

Ascent Group increased its CVS Health (CVS) stake by 1.4% in Q1 2026, buying an estimated $9.47K and bringing the position to 9,207 shares worth $661K. The position accounts for 0.02% of the portfolio, ranked #443.

Ascent Group first reported a position in CVS in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.96M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Ascent Group held 9,207 shares of CVS Health worth $661K as of Q1 2026.
  • Ascent Group bought 123 CVS Health shares in Q1 2026, an estimated $9.47K.
  • CVS Health made up 0.02% of Ascent Group's portfolio in Q1 2026, its #443 holding.
  • Ascent Group first reported a position in CVS Health in Q4 2021 and has held it in 15 quarters since.
  • Ascent Group's CVS Health position peaked at $1.96M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.